Literature DB >> 10534341

Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic Rat.

D Harry1, R Anand, S Holt, S Davies, R Marley, B Fernando, D Goodier, K Moore.   

Abstract

Sepsis is a common complication of cirrhosis with a high mortality. In this study, we have investigated some of the pathways that may be involved in tissue injury and death. Bile duct-ligated (BDL) cirrhotic and control rats were challenged with lipopolysaccharide (LPS). Sensitivity to LPS was markedly enhanced in the BDL group, and was associated with increased liver injury and mortality. There was a 5-fold constitutive activation of nuclear factor kappa B (NFkappaB) in the liver of BDL rat controls (P <.001), and this was activated further, but to a similar extent, in the liver of both sham and BDL rats after injection of LPS. Plasma tumor necrosis factor alpha (TNF-alpha) increased more markedly in the BDL cirrhotic rats (2,463 +/- 697 pg/mL in BDL rats versus 401 +/- 160 pg/mL in the controls at 3 hours; P <.01). Plasma nitrite/nitrate concentrations were increased in the BDL controls at baseline, and increased further after LPS (P <.05), but did not differ from sham controls at 6 hours. Plasma F(2)-isoprostanes increased 6-fold in the cirrhotic rats and 2-fold in the controls (P <.01) indicative of lipid peroxidation. Esterified F(2)-isoprostanes in the liver increased 2- to 3-fold at 1 hour in control and BDL rats, but returned to baseline levels by 3 hours. Esterified F(2)-isoprostanes in the kidney increased by 2-fold in the BDL rats after LPS administration, but remained unchanged in sham controls. We conclude that there is a marked increase in sensitivity to LPS in BDL cirrhotic rats. This is associated with an enhanced TNF-alpha response and increased lipid peroxidation. These may be directly and causally related to mortality.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534341     DOI: 10.1002/hep.510300515

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

Review 1.  Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress.

Authors:  Balasubramaniyan Vairappan
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Gut Microbiota of Nonalcoholic Fatty Liver Disease.

Authors:  Reham M Abdou; Lixin Zhu; Robert D Baker; Susan S Baker
Journal:  Dig Dis Sci       Date:  2016-02-22       Impact factor: 3.199

3.  A modified "double-hit" induced acute lung injury model in rats and protective effects of tetramethylpyrazine on the injury via Rho/ROCK pathway.

Authors:  Shidi Zhao; Yong Zhang; Qianfen Chen; Shuying Dong; Gaofeng Zhang; Jia Li; Xilan Yang; Yan Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Abnormal brain oxygen homeostasis in an animal model of liver disease.

Authors:  Anna Hadjihambi; Cristina Cudalbu; Katarzyna Pierzchala; Dunja Simicic; Chris Donnelly; Christos Konstantinou; Nathan Davies; Abeba Habtesion; Alexander V Gourine; Rajiv Jalan; Patrick S Hosford
Journal:  JHEP Rep       Date:  2022-05-24

5.  Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.

Authors:  A Giacometti; O Cirioni; R Ghiselli; F Mocchegiani; G D'Amato; M Simona Del Prete; F Orlando; W Kamysz; J Lukasiak; V Saba; G Scalise
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

6.  LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction.

Authors:  Rebecca M Minter; Xiaoming Bi; Gal Ben-Josef; Tianyi Wang; Bin Hu; Saman Arbabi; Mark R Hemmila; Stewart C Wang; Daniel G Remick; Grace L Su
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-23       Impact factor: 4.052

7.  Cardiac-induced liver deformation as a measure of liver stiffness using dynamic imaging without magnetization tagging-preclinical proof-of-concept, clinical translation, reproducibility and feasibility in patients with cirrhosis.

Authors:  Manil D Chouhan; Heather E Fitzke; Alan Bainbridge; David Atkinson; Steve Halligan; Nathan Davies; Mark F Lythgoe; Rajeshwar P Mookerjee; Alex Menys; Stuart A Taylor
Journal:  Abdom Radiol (NY)       Date:  2021-06-20

8.  Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats.

Authors:  W Urbanowicz; P Sogni; R Moreau; K A Tazi; E Barriere; O Poirel; A Martin; M C Guimont; D Cazals-Hatem; D Lebrec
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

9.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03

10.  Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease.

Authors:  Sorina Georgiana Boaru; Erawan Borkham-Kamphorst; Lidia Tihaa; Ute Haas; Ralf Weiskirchen
Journal:  J Inflamm (Lond)       Date:  2012-11-28       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.